Grand Canal Land PCL (GLAND)

Currency in THB
0.620
-0.010(-1.59%)
Delayed Data·
Showing Grand Canal Land historical data. For real-time data please try another search
Fair Value
Day's Range
0.6200.730
52 wk Range
0.3400.730
Key Statistics
Bid/Ask
0.62 / 0.66
Prev. Close
0.63
Open
0.63
Day's Range
0.62-0.73
52 wk Range
0.34-0.73
Volume
10.55M
Average Volume (3m)
10.04M
1-Year Change
-16.2162%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GLAND Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Grand Canal Land PCL News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell

Grand Canal Land PCL Earnings Call Summary for Q1/2027

  • Gland Pharma Q1 revenue rose 20% YoY to INR 18,003M; adjusted EBITDA margin expanded 300bps to 28%; PAT surged 47% to INR 3,170M despite forex headwinds.
  • CDMO business now accounts for 50% of total sales at INR 8,915M, reflecting strategic shift toward higher-value contract manufacturing with better visibility.
  • Company signed major manufacturing deal with global specialty pharma expected to generate $90-100M annually starting 2029; technology transfer begins Sept 2026.
  • Management raised four-year growth target to 20% CAGR from 15%; reaffirmed FY27 guidance of 15% constant-currency growth with possible upside from FDA approvals.
  • Stock flat at $0.74 near 52-week low; Cenexi targeting EUR 200M revenue and double-digit EBITDA margins by year-end; INR 550 crore FY27 capex planned.
Last Updated: 2026-08-10, 10:38 a/m
Read Full Transcript

Earnings

Latest Release
Aug 06, 2026
EPS / Forecast
0.02 / --
Revenue / Forecast
404M / --
EPS Revisions
Last 90 days

GLAND Income Statement

Compare GLAND to Peers and Sector

Metrics to compare
GLAND
Peers
Sector
Relationship
P/E Ratio
9.8x7.7x8.4x
PEG Ratio
−0.60−0.310.01
Price/Book
0.2x0.5x0.9x
Price / LTM Sales
2.6x0.8x3.9x
Upside (Analyst Target)
-10.9%23.3%
Fair Value Upside
Unlock9.8%2.0%Unlock

People Also Watch

3.76
ERW
0.00%
1.170
PROUD
0.00%
1.64
SCAP
+1.86%
15.10
TSC
0.00%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.